Colgate announces changes to its board of directors, including the resignation of Joseph Jimenez, CEO of Novartis.
Progress at re-opening its manufacturing facility in Lincoln, Neb., has been slow-going, Novartis reported Thursday, but the company has contracted third-party manufacturers to resume production of Excedrin, Lamisil and Triaminic.
Novartis on Thursday morning named Naomi Kelman head of the Novartis OTC division, effective March 2. She will report directly to Joseph Jimenez, Novartis CEO.
Colgate-Palmolive appointed Helene Gayle, president and CEO of Care USA, and Joseph Jimenez, CEO of...